{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:18:39Z","timestamp":1783448319993,"version":"3.55.0"},"reference-count":15,"publisher":"Bioscientifica","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":165,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Radiofrequency ablation (RFA) has emerged as a minimally invasive and effective alternative to surgery for benign thyroid nodules, providing a significant volume reduction and symptom relief. However, approximately one in five patients experiences regrowth requiring retreatment. This study aimed to identify robust predictive factors \u2013 spanning the pre-, peri-, and post-treatment periods \u2013 to guide patient selection and follow-up strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective cohort study, 293 patients underwent RFA for benign thyroid nodules at Piti\u00e9-Salp\u00eatri\u00e8re Hospital between 2018 and 2023. Retreatment, defined as a second RFA within five years, was the primary outcome. Twelve clinical and treatment variables were analyzed using univariate and multivariate logistic regression. Predictive performance was assessed with receiver operating characteristic (ROC) curves and corresponding area under the curve (AUC) values.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sixty-one patients (20.8%) required retreatment. Among twelve parameters from three periods (pre-treatment, peri-treatment, and post-treatment), optimal multivariate models identified six significant ones. The pre-treatment growth rate (AUC = 0.808, OR = 1.505, 95% CI: 1.182\u20131.952, P &amp;lt; 0.001) and six-month viable volume (AUC = 0.886, OR = 1.252, 95% CI: 1.088\u20131.496, P &amp;lt; 0.001) showed the highest predictive accuracy. Optimal thresholds were 1.75 mm\/year for pre-treatment growth rate and 4.45 mL for viable volume. Patients with viable volume \u2264 2.1 mL had a &amp;lt;5% risk of retreatment, compared to &amp;gt;70% when viable volume exceeded 18.05 mL. Four predictive abacuses were developed to facilitate clinical application.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Pre-treatment growth rate and six-month viable volume are strong, independent predictors of retreatment after RFA of benign thyroid nodules. Incorporating these parameters into clinical decision-making may enhance patient selection, tailor treatment intensity, and inform follow-up intervals, thereby reducing the risk of retreatment and improving cost-effectiveness.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/etj-25-0254","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T18:28:03Z","timestamp":1771266483000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-17","source":"Crossref","is-referenced-by-count":0,"title":["Predictors of retreatment after radiofrequency ablation of benign thyroid nodules: role of pre-treatment growth rate and viable volume"],"prefix":"10.1530","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4986-8658","authenticated-orcid":true,"given":"Adrien","family":"Ben Hamou","sequence":"first","affiliation":[{"name":"1"},{"name":"2"},{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Guillaume","family":"Marchand","sequence":"additional","affiliation":[{"name":"1"},{"name":"3"},{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Poiree","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Ghander","sequence":"additional","affiliation":[{"name":"1"},{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Buffet","sequence":"additional","affiliation":[{"name":"1"},{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Russ","sequence":"additional","affiliation":[{"name":"1"},{"name":"3"},{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"2026070713593537500_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3348\/kjr.2024.0599","article-title":"Radiofrequency ablation of benign thyroid nodules: 10-year follow-up results from a single center","volume":"26","author":"Shin","year":"2025","journal-title":"Korean J Radiol"},{"key":"2026070713593537500_bib2","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1089\/thy.2024.0082","article-title":"Radiofrequency ablation for the treatment of benign thyroid nodules: 10-year experience","volume":"34","author":"Park","year":"2024","journal-title":"Thyroid"},{"key":"2026070713593537500_bib3","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1089\/thy.2020.0202","article-title":"Five-year results of radiofrequency and laser ablation of benign thyroid nodules: a multicenter study from the Italian minimally invasive treatments of the thyroid group","volume":"30","author":"Bernardi","year":"2020","journal-title":"Thyroid"},{"key":"2026070713593537500_bib4","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1089\/thy.2023.0281","article-title":"General principles for the safe performance, training, and adoption of ablation techniques for benign thyroid nodules: an American thyroid Association statement","volume":"33","author":"Sinclair","year":"2023","journal-title":"Thyroid"},{"key":"2026070713593537500_bib5","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1089\/thy.2018.0604","article-title":"Image-guided thyroid ablation: proposal for standardization of terminology and reporting criteria","volume":"29","author":"Mauri","year":"2019","journal-title":"Thyroid"},{"key":"2026070713593537500_bib6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s40477-024-00898-5","article-title":"Superb microvascular imaging (SMI) and elastosonography in thyroid nodule: diagnostic value in a real-time cohort","volume":"27","author":"Negroni","year":"2024","journal-title":"J Ultrasound"},{"key":"2026070713593537500_bib7","first-page":"905","article-title":"Radiofrequency ablation of benign thyroid nodules: depicting early sign of regrowth by calculating vital volume","volume":"33","author":"Sim","year":"2017","journal-title":"Int J Hyperthermia"},{"key":"2026070713593537500_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/kjm2.70089","article-title":"Long-term outcomes of radiofrequency ablation for benign thyroid nodules of different sizes: implications of regrowth and new growth","volume":"42","author":"Lu","year":"2026","journal-title":"Kaohsiung J Med Sci"},{"key":"2026070713593537500_bib9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/02656736.2020.1778197","article-title":"Vital volume increase versus clinical evaluation as the indication of additional radiofrequency ablation for benign thyroid nodule: a single center retrospective study","volume":"37","author":"Yan","year":"2020","journal-title":"Int J Hyperthermia"},{"key":"2026070713593537500_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.582550","article-title":"Initial ablation ratio predicts volume reduction and retreatment after 5 years from radiofrequency ablation of benign thyroid nodules","volume":"11","author":"Bernardi","year":"2021","journal-title":"Front Endocrinol"},{"key":"2026070713593537500_bib11","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1007\/s00330-020-07532-y","article-title":"Determining an energy threshold for optimal volume reduction of benign thyroid nodules treated by radiofrequency ablation","volume":"31","author":"Deandrea","year":"2021","journal-title":"Eur Radiol"},{"key":"2026070713593537500_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/02656736.2021.1871974","article-title":"Learning curve for radiofrequency ablation of benign thyroid nodules","volume":"38","author":"Russ","year":"2021","journal-title":"Int J Hyperthermia"},{"key":"2026070713593537500_bib13","article-title":"Advances in influence factors of ultrasound-guided percutaneous thermal ablations for benign thyroid nodules: a review","volume":"103","author":"Wang","year":"2024","journal-title":"Medicine"},{"key":"2026070713593537500_bib14","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1148\/radiol.12111300","article-title":"Symptomatic benign thyroid nodules: efficacy of additional radiofrequency ablation treatment session \u2013 prospective randomized study","volume":"263","author":"Huh","year":"2012","journal-title":"Radiology"},{"key":"2026070713593537500_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.surg.2024.06.078","article-title":"Early second radiofrequency ablation treatment gave rise to significantly greater nodule shrinkage at 12 months than single-session treatment for large-volume benign thyroid nodules","volume":"177","author":"Fung","year":"2025","journal-title":"Surgery"}],"container-title":["European Thyroid Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/etj.bioscientifica.com\/view\/journals\/etj\/15\/1\/ETJ-25-0254.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/etj.bioscientifica.com\/downloadpdf\/journals\/etj\/15\/1\/ETJ-25-0254.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-25-0254\/508635\/etj-25-0254.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-25-0254\/508635\/etj-25-0254.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:59:45Z","timestamp":1783447185000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article\/15\/1\/ETJ250254\/75591\/Predictors-of-retreatment-after-radiofrequency"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.1530\/etj-25-0254","relation":{},"ISSN":["2235-0802","2235-0640"],"issn-type":[{"value":"2235-0802","type":"electronic"},{"value":"2235-0640","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"ETJ250254"}}